• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Open Versus Thoracoscopic Esophagectomy Across Pathological Stages in Esophageal Squamous Cell Carcinoma: Consistent Survival Benefit with a Minimally Invasive Approach.

作者信息

Jia Xiaocan, Gao Yishuo, Ren Tongtong, Chen Peinan, Yang Funa, Zhang Yi, Yang Yongli

机构信息

Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Henan, China.

Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan, China.

出版信息

Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17724-9.

DOI:10.1245/s10434-025-17724-9
PMID:40549084
Abstract
摘要

相似文献

1
ASO Author Reflections: Open Versus Thoracoscopic Esophagectomy Across Pathological Stages in Esophageal Squamous Cell Carcinoma: Consistent Survival Benefit with a Minimally Invasive Approach.ASO作者反思：食管鳞状细胞癌不同病理阶段的开放手术与胸腔镜下食管切除术对比：微创方法带来持续生存获益
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17724-9.
2
Survival Comparison Between Open and Thoracoscopic Esophagectomy for Esophageal Squamous Cell Carcinoma Stratified by Pathological Tumor-Node-Metastasis Stage: An Overlap Weighting Analysis.根据病理肿瘤-淋巴结-转移分期分层的开放性与胸腔镜下食管癌切除术治疗食管鳞状细胞癌的生存比较：重叠加权分析
Ann Surg Oncol. 2025 Jun 4. doi: 10.1245/s10434-025-17567-4.
3
ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.ASO作者反思：淋巴结比率是微创食管切除术后食管鳞状细胞癌的独立预后因素。
Ann Surg Oncol. 2021 Aug;28(8):4529. doi: 10.1245/s10434-020-09452-z. Epub 2021 Jan 5.
4
ASO Author Reflections: Better Long-Term Survival in Esophageal Cancer After Minimally Invasive Versus Open Transthoracic Esophagectomy in Sweden: A Population-Based Cohort Study.ASO作者反思：瑞典微创与开放经胸食管切除术治疗食管癌后的长期生存率更高：一项基于人群的队列研究。
Ann Surg Oncol. 2022 Sep;29(9):5622-5623. doi: 10.1245/s10434-022-11924-3. Epub 2022 Jun 17.
5
Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者开放性与胸腔镜下食管切除术的比较
World J Surg. 2014 Feb;38(2):402-9. doi: 10.1007/s00268-013-2265-5.
6
ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.ASO作者反思：T1N0期食管鳞状细胞癌患者非根治性内镜切除术后追加食管切除术与直接食管切除术的比较
Ann Surg Oncol. 2021 Sep;28(9):4867-4868. doi: 10.1245/s10434-020-09502-6. Epub 2021 Jan 25.
7
Outcomes of Older Patients Undergoing Surgery for Esophageal Squamous Cell Carcinoma.老年食管鳞状细胞癌患者手术治疗的结果
In Vivo. 2025 Jul-Aug;39(4):2286-2294. doi: 10.21873/invivo.14024.
8
ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.ASO作者反思：结节性跳跃转移与胸段食管鳞状细胞癌的生存获益相关。
Ann Surg Oncol. 2021 Oct;28(11):6353-6354. doi: 10.1245/s10434-020-09571-7. Epub 2021 Feb 4.
9
ASO Author Reflections: Superior Postoperative Outcomes from Completely Minimally Invasive Approach Versus Hybrid Approach to Esophagectomy for Esophageal and Gastro-Esophageal Junctional Cancer.ASO作者反思：与食管癌和食管胃交界癌的杂交食管切除术相比，完全微创方法术后效果更佳。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):828-829. doi: 10.1245/s10434-020-08838-3. Epub 2020 Jul 10.
10
Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.临床工具无法预测接受根治性放化疗的食管鳞癌患者的病理完全缓解。
Dis Esophagus. 2014 May-Jun;27(4):355-9. doi: 10.1111/dote.12126. Epub 2013 Aug 29.

引用本文的文献

1
ASO Author Reflections: Artificial Intelligence in Bladder Cancer-Transforming Diagnosis and Treatment Paradigms.ASO作者反思：膀胱癌中的人工智能——变革诊断与治疗模式
Ann Surg Oncol. 2025 Aug;32(8):6189-6190. doi: 10.1245/s10434-025-17538-9. Epub 2025 May 28.

本文引用的文献

1
Comparison of Partial Nephrectomy Versus Radical Nephrectomy for Metastatic Renal Cell Carcinoma in the Immunotherapy Era: A Propensity Score Matching, Population-Based Analysis.免疫治疗时代转移性肾细胞癌行部分肾切除术与根治性肾切除术的比较：一项倾向评分匹配的基于人群的分析
Ann Surg Oncol. 2025 Jun 19. doi: 10.1245/s10434-025-17642-w.
2
Long-term Survival in Esophageal Cancer: Comparison of Minimally Invasive and Open Esophagectomy.食管癌的长期生存：微创与开放食管切除术的比较
Ann Thorac Surg. 2025 Apr;119(4):805-814. doi: 10.1016/j.athoracsur.2024.09.004. Epub 2024 Sep 12.
3
Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients With Esophageal Squamous Cell Carcinoma.
开放与胸腔镜 upfront 食管切除术治疗食管鳞癌患者的生存比较。
Ann Surg. 2023 Jan 1;277(1):e53-e60. doi: 10.1097/SLA.0000000000004968. Epub 2021 Jun 10.
4
Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database.微创食管癌切除术能否替代开放性食管癌切除术？日本国家临床数据库 24233 例食管癌切除术的最新分析。
Ann Surg. 2020 Jul;272(1):118-124. doi: 10.1097/SLA.0000000000003222.
5
Epidemiology of Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的流行病学
Gastroenterology. 2018 Jan;154(2):360-373. doi: 10.1053/j.gastro.2017.08.023. Epub 2017 Aug 18.